Thus, we estimate revenue, EBITDA and PAT CAGR of 20.6%, 16.2% and 8.8%, respectively, in FY18-21E. We value CSL at 11x FY21E earnings to arrive at target price of Rs 410/share. We maintain BUY recommendation on the company.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.